Kuehne + Nagel International AG (OTCMKTS:KHNGY – Get Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $45.84 and last traded at $45.87, with a volume of 50959 shares changing hands. The stock had previously closed at $47.72.
Wall Street Analyst Weigh In
KHNGY has been the subject of several recent analyst reports. Citigroup raised shares of Kuehne + Nagel International to a “strong sell” rating in a research note on Wednesday, October 9th. Barclays raised Kuehne + Nagel International to a “hold” rating in a research report on Friday, September 27th. Finally, UBS Group upgraded Kuehne + Nagel International to a “hold” rating in a research note on Tuesday, October 1st.
View Our Latest Stock Report on Kuehne + Nagel International
Kuehne + Nagel International Price Performance
Kuehne + Nagel International (OTCMKTS:KHNGY – Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.01. Kuehne + Nagel International had a return on equity of 37.72% and a net margin of 4.83%. The business had revenue of $7.50 billion during the quarter. As a group, equities analysts anticipate that Kuehne + Nagel International AG will post 2.37 EPS for the current year.
Kuehne + Nagel International Company Profile
Kuehne + Nagel International AG, together with its subsidiaries, provides integrated logistics services worldwide. The company operates through four segments: Sea Logistics, Air Logistics, Road Logistics, and Contract Logistics. It offers less-than-container load, reefer and project logistics, and flexible container shipping solutions.
Further Reading
- Five stocks we like better than Kuehne + Nagel International
- Energy and Oil Stocks Explained
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- With Risk Tolerance, One Size Does Not Fit All
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is Insider Trading? What You Can Learn from Insider Trading
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Kuehne + Nagel International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kuehne + Nagel International and related companies with MarketBeat.com's FREE daily email newsletter.